MEKICS, a leading provider of respiratory care solutions, is proud to announce that it has received final approval from the Ministry of Food and Drug Safety (MFDS) for its patient monitoring software, "MP607" (product name: Patient Monitoring Software) on June 24, 2024.

The "MP607" software leverages wireless communication networks to centralize and monitor patient data from multiple monitoring devices or ventilators within the same network. This innovative solution allows healthcare professionals to efficiently oversee the operational status and alarms of numerous devices from the nurse station or anywhere within the facility via various applications, eliminating the need for direct visits to patient rooms.

A company representative stated, "This approval marks a significant milestone, positioning MEC not just as a manufacturer of respiratory therapy devices, but as a provider of advanced, data-driven respiratory care solutions. We anticipate that the integrated sale of our newly launched ventilator (MV50) and our pioneering high-flow therapy device, OmniOx, will further expand the horizons of respiratory care."